Published in Lab Law Weekly, December 15th, 2006
The company reported its EPS doubled, its net income more than doubled and its gross margins improved sequentially during the third quarter. Management believes this positive trend in performance will remain intact in future quarters.
Revenues for the third quarter ended September 30, 2006 totaled $7,023,891, a 12.4% increase from revenues of $6,249,343 for the quarter ended September 30, 2005 and a sequential decrease of 3.6% from revenues of $7,284,888 for the quarter...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly